Marker TherapeuticsMRKR
13F holders, Q2 2025 (June 30)31holders
2new positions
3sold out
1famous investor
$1.53avg. 13F price*
At the end of Q2 2025, 31 institutions reported holding Marker Therapeutics Inc. (MRKR) in their 13F filings, unchanged from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were NEA Management Company, LLC ($2.5M), Blue Owl Capital Holdings LP ($848K) and Aisling Capital Management LP ($498K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Marker Therapeutics Inc.
- CUSIP
- 57055L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $48K |
| Exits | 3 | $668K |
All 13F filers, Q1 2025 → Q2 2025: 41,436 shares bought and 654,558 shares sold, net −613,122 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| NEA Management Company, LLC | 0.19% | No change | 1,625,678 | $2.5M |
| Blue Owl Capital Holdings LP | 0.28% | No change | 554,250 | $848K |
| Aisling Capital Management LP | 0.14% | No change | 325,370 | $498K |
| Vanguard Group Inc. | 0.00% | No change | 275,345 | $421K |
| Alyeska Investment Group, L.P. | 0.00% | Reduce -18.6% | 213,020 | $326K |
| Geode Capital Management, LLC | 0.00% | Add +8.0% | 95,768 | $147K |
| LPL Financial LLC | 0.00% | Add +0.7% | 73,747 | $113K |
| Renaissance Technologies | 0.00% | Reduce -16.9% | 69,442 | $106K |
| Invst, LLC | 0.00% | No change | 23,400 | $36K |
| Jane Street Group, LLC | 0.00% | New | 21,800 | $33K |
| State Street Corp. | 0.00% | No change | 20,948 | $32K |
| Osaic Holdings, Inc. | 0.00% | Add +9.1% | 19,577 | $30K |
| Creative Planning | 0.00% | No change | 17,312 | $26K |
| Dimensional Fund Advisors LP | 0.00% | No change | 15,900 | $24K |
| Matrix Asset Advisors Inc. | 0.00% | No change | 15,000 | $23K |
| Susquehanna International Group, LLP | 0.00% | Reduce -59.9% | 12,437 | $19K |
| Northern Trust Corp. | 0.00% | No change | 10,857 | $17K |
| Raymond James Financial Inc. | 0.00% | New | 9,515 | $15K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +5.8% | 3,375 | $5K |
| SBI Securities Co., Ltd. | 0.00% | Add +41.6% | 1,703 | $3K |
| UBS Group AG | 0.00% | Reduce -88.8% | 1,600 | $2K |
| Riggs Asset Managment Co. Inc. | 0.00% | No change | 1,200 | $2K |
| Bank of America Corp. | 0.00% | Reduce -65.5% | 1,114 | $2K |
| BlackRock, Inc. | 0.00% | Reduce -93.9% | 992 | $2K |
| Morgan Stanley | 0.00% | Add +2.0% | 401 | $613 |
| Wells Fargo & Company | 0.00% | No change | 232 | $355 |
| JPMorgan Chase & Co. | 0.00% | Add +497.2% | 215 | $329 |
| Group One Trading LLC | 0.00% | No change | 178 | $272 |
| Hilltop National Bank | 0.00% | — | 73 | $112 |
| BNP Paribas Financial Markets | 0.00% | No change | 23 | $35 |
| Versant Capital Management, Inc | 0.00% | No change | 15 | $23 |
"% of holder's portfolio" is MRKR's weight in each manager's 13F, not the share of Marker Therapeutics Inc. the manager owns.